Fluor Corp (FLR) Q3 2026 Earnings Call Transcript

Fluor reported record third-quarter awards of $10.9 billion and backlog of $34.3 billion, up 21% year over year, while revenue rose 10% to $3.72 billion and adjusted EPS increased 13% to $0.77. Management reaffirmed 2026 adjusted EBITDA guidance of $500 million–$525 million and adjusted EPS guidance of $2.70–$2.80; it expects low-double-digit EBITDA growth in 2027, excluding technology transformation costs. Positives were tempered by adjusted EBITDA declining to $142 million from $161 million and a possible approximately $2 billion backlog reduction tied to a reimbursable client's project-scope change, still under evaluation. Fluor repurchased $300 million of shares in Q3 and remains on pace for $1.4 billion in 2026 repurchases.

Analysis

The key issue is conversion, not award volume. Large EPC awards can support utilization and overhead absorption, but generally take time to reach peak execution; therefore near-term backlog growth is not equivalent to near-term earnings growth. For FLR, a possible $2B scope removal from reimbursable work is more concerning as a utilization and schedule signal than as a direct margin shock, but the client’s final scope and timing remain unverified. The recurring execution risk is visible in the mining charge: negotiated change orders can contain a loss without proving the underlying estimating and delivery process is fixed.

The improving 2027-28 utilization narrative is plausible, but depends on client board approvals, project releases, and disciplined execution across a very large procurement footprint. A slip in those approvals would leave the company carrying overhead before new awards contribute meaningfully. Buybacks support per-share results, but should not be mistaken for improving project economics; the EBITDA decline and ECA Fluor gain also make headline comparisons less clean.

TeraWulf’s potential Kentucky build-out is an opportunity for project activity, not yet evidence of realized FLR earnings or favorable contract economics. For WULF, the corresponding second-order risk is that construction commitments precede the economics and operating readiness of the data-center site. X-energy’s project activity adds long-dated option value, not a near-term nuclear earnings catalyst; Bayer’s feasibility work is similarly early-stage.

Net: constructive on FLR’s medium-term workload, cautious on timing and execution. No immediate chase without confirmation that scope reductions are contained and incoming work converts to profitable execution.

Key Decisions for Investors

• FLR: Avoid adding on the awards headline alone. Consider a staged long only after Q4 clarifies the reimbursable scope reduction and demonstrates backlog conversion without another material project charge. Falsify the thesis if scope removals broaden, mining costs recur, or 2027 growth assumptions are cut.
• FLR: Track project-level margin and utilization commentary, not just book-to-burn. A delay in client approvals for power or mining awards would push the earnings ramp out and weaken the medium-term long thesis.
• WULF: Treat the anticipated FLR award as a project-development catalyst, not proof of site economics. Verify final contract scope, funding/capex commitments, and delivery milestones before trading through the construction narrative.
• XE and BAYN: No standalone trade from these mentions; both are early-stage indicators of potential future work rather than evidence of near-term revenue or earnings contribution.